Biblio

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A

Xia K, Wang F, Lai X, Dong L, Luo P, Zhang S, Yang C, Chen H, Ma Y, Huang W, et al. AAV-mediated gene therapy produces fertile offspring in the Lhcgr-deficient mouse model of Leydig cell failure. Cell Rep Med. 2022:100792.

Sun Q, Zhang L, Chen T, Li N, Tan F, Gu X, Zhou Y, Zhang Z, Lu Y, Lu J, et al. AAV-mediated Gpm6b expression supports hair cell reprogramming. Cell Prolif. 2024:e13620.

Zhang L, Fang Y, Tan F, Guo F, Zhang Z, Li N, Sun Q, Qi J, Chai R. AAV-Net1 facilitates the trans-differentiation of supporting cells into hair cells in the murine cochlea. Cell Mol Life Sci. 2023;80(4):86.

Sladen PE, Naeem A, Adefila-Ideozu T, Vermeule T, Busson SL, Michaelides M, Naylor S, Forbes A, Lane A, Georgiadis A. AAV-RPGR Gene Therapy Rescues Opsin Mislocalisation in a Human Retinal Organoid Model of -Associated X-Linked Retinitis Pigmentosa. Int J Mol Sci. 2024;25(3).

Senís E, Mosteiro L, Wilkening S, Wiedtke E, Nowrouzi A, Afzal S, Fronza R, Landerer H, Abad M, Niopek D, et al. AAVvector-mediated in vivo reprogramming into pluripotency. Nat Commun. 2018;9(1):2651.

Miao Q, Wang F, Dou J, Iqbal R, Muftuoglu M, Basar R, Li L, Rezvani K, Chen K. Ab initio Spillover Compensation in CyTOF Data. Cytometry A. 2020.

Beier MPascal, Jinno C, Noda N, Nakamura K, Sugano S, Suzuki Y, Fujita T. ABA signaling converts stem cell fate by substantiating a tradeoff between cell polarity, growth and cell cycle progression and abiotic stress responses in the moss . Front Plant Sci. 2023;14:1303195.

Wertheimer T, Dohse M, Afram G, Weber D, Heidenreich M, Holler B, Kattner A-S, Neubauer A, Mielke S, Ljungman P, et al. Abatacept as salvage therapy in chronic graft-versus-host disease-a retrospective analysis. Ann Hematol. 2021.

Qayed M, Watkins B, Gillespie S, Bratrude B, Betz KM, Choi SWon, Davis JH, Duncan C, Giller RH, Grimley M, et al. Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation. Blood Adv. 2021.

Ngwube A, Shah N, Godder K, Jacobsohn D, Hulbert ML, Shenoy S. Abatacept is effective as GVHD prophylaxis in unrelated donor stem cell transplantation for children with severe sickle cell disease. Blood Adv. 2020;4(16):3894-3899.

Gabelli M, Pérez-Martínez A, Sánchez DBueno, Lucchini G, Grenier L-P, Couture F, Limerick E, Bernaud V, Del Castillo MTrabazo, Ngwube A. Abatacept treatment for autoimmune hemolytic anemia occurring post hematopoietic stem cell transplantation. Bone Marrow Transplant. 2023.

Busuioc C, Birla RDaniela, Ultimescu F, Duţulescu S, Panaitescu E, Berindan-Neagoe I. Abberant Immunohistochemical Expression of OCT3/4 and EMT Related Markers, Vimentin and E-cadherin, is Correlated with Adverse Histopathological Features in Colorectal Adenocarcinoma. Chirurgia (Bucur). 2022;117(5):544-555.

Massumi M, Pourasgari F, Nalla A, Batchuluun B, Nagy K, Neely E, Gull R, Nagy A, Wheeler MB. An Abbreviated Protocol for In Vitro Generation of Functional Human Embryonic Stem Cell-Derived Beta-Like Cells. PLoS One. 2016;11(10):e0164457.

Rama AR, Alvarez PJ, Madeddu R, Aránega A. ABC transporters as differentiation markers in glioblastoma cells. Mol Biol Rep. 2014.

Viaud M, Abdel-Wahab O, Gall J, Ivanov S, Guinamard R, Sore S, Merlin J, Ayrault M, Guilbaud E, Jacquel A, et al. ABCA1 Exerts Tumor-Suppressor Function in Myeloproliferative Neoplasms. Cell Rep. 2020;30(10):3397-3410.e5.

Coyle B, Kessler M, Sabnis DH, Kerr ID. ABCB1 in children's brain tumours. Biochem Soc Trans. 2015;43(5):1018-1022.

Yahagi A, Mochizuki-Kashio M, Sorimachi Y, Takubo K, Nakamura-Ishizu A. Abcb10 regulates murine hematopoietic stem cell potential and erythroid differentiation. Exp Hematol. 2024:104191.

Louphrasitthiphol P, Chauhan J, Goding CR. ABCB5 is activated by MITF andβ-catenin and is associated with melanoma differentiation. Pigment Cell Melanoma Res. 2019.

Dieter K, Niebergall-Roth E, Daniele C, Fluhr S, Frank NY, Ganss C, Kiritsi D, McGrath JA, Tolar J, Frank MH, et al. ABCB5 mesenchymal stromal cells facilitate complete and durable wound closure in recessive dystrophic epidermolysis bullosa. Cytotherapy. 2023.

Chen Y-H, Cimino PJ, Luo J, Dahiya S, Gutmann DH. ABCG1 maintains high-grade glioma survival in vitro and in vivo. Oncotarget. 2016.

Leccia F, Del Vecchio L, Mariotti E, Di Noto R, Morel A-P, Puisieux A, Salvatore F, Ansieau S. ABCG2, a novel antigen to sort luminal progenitors of BRCA1- breast cancer cells. Mol Cancer. 2014;13(1):213.

Damiani D, Tiribelli M, Geromin A, Cerno M, Zanini F, Michelutti A, Fanin R. ABCG2, Cytogenetic and Age Predict Relapse after Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Complete Remission. Biol Blood Marrow Transplant. 2016.

Kawai N, Hirohashi Y, Ebihara Y, Saito T, Murai A, Saito T, Shirosaki T, Kubo T, Nakatsugawa M, Kanaseki T, et al. ABCG2 expression is related to low 5-ALA photodynamic diagnosis (PDD) efficacy and cancer stem cell phenotype, and suppression of ABCG2 improves the efficacy of PDD. PLoS One. 2019;14(5):e0216503.

Szepesi A, Matula Z, Szigeti A, Várady G, Szabó G, Uher F, Sarkadi B, Német K. ABCG2 is a selectable marker for enhanced multilineage differentiation potential in periodontal ligament stem cells. Stem Cells Dev. 2014.

Ling X, Wu W, Fan C, Xu C, Liao J, Rich LJ, Huang R-Y, Repasky EA, Wang X, Li F. An ABCG2 non-substrate anticancer agent FL118 targets drug-resistant cancer stem-like cells and overcomes treatment resistance of human pancreatic cancer. J Exp Clin Cancer Res. 2018;37(1):240.

Pages